|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
45,510,000 |
Market
Cap: |
17.34(B) |
Last
Volume: |
20,609,857 |
Avg
Vol: |
7,325,175 |
52
Week Range: |
$381.02 - $381.02 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Instruments & Supplies |
|
Member Indexes:
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile ABIOMED is a provider of medical devices that provide circulatory support and oxygenation. Co.'s existing products include: Impella 2.5®, which is a percutaneous heart pump with a motor and sensors; Impella CP®, which is primarily used by either interventional cardiologists to support patients in the cath lab or by cardiac surgeons in the heart surgery suite; Impella 5.0® and Impella LD®, which are percutaneous heart pumps with motors and sensors for use primarily in the heart surgery suite; Impella 5.5®, which is designed to be a percutaneous heart pump with motors and sensors; and Abiomed Breethe OXY-1 System, which is a portable external respiratory assistance device.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
11,544 |
Total Sell Value |
$0 |
$0 |
$0 |
$4,345,727 |
Total People Sold |
0 |
0 |
0 |
5 |
Total Sell Transactions |
0 |
0 |
0 |
6 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Minogue Michael R |
Chairman, President, CEO |
|
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
30,646 |
396,279 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2019-05-16 |
4 |
D |
$259.68 |
$215,015 |
D/D |
(828) |
52,095 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,179 |
52,923 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-05-16 |
4 |
D |
$259.68 |
$333,948 |
D/D |
(1,286) |
149,157 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
6,268 |
150,443 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2019-05-16 |
4 |
D |
$259.68 |
$80,501 |
D/D |
(310) |
7,133 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2019-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
2,089 |
7,443 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2019-05-15 |
4 |
D |
$256.69 |
$449,464 |
D/D |
(1,751) |
42,252 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2019-05-15 |
4 |
D |
$256.69 |
$380,415 |
D/D |
(1,482) |
60,700 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2019-05-15 |
4 |
D |
$256.69 |
$2,712,700 |
D/D |
(10,568) |
365,633 |
|
- |
|
Howley Michael G |
VP, Global Sales & Marketing |
|
2019-05-15 |
4 |
D |
$256.69 |
$448,694 |
D/D |
(1,748) |
48,744 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-05-15 |
4 |
A |
$256.69 |
$256,690 |
D/D |
1,000 |
144,175 |
|
- |
|
Weber David M |
Chief Operating Officer |
|
2019-05-15 |
4 |
D |
$256.69 |
$684,592 |
D/D |
(2,667) |
145,175 |
|
- |
|
Sutter Martin P |
Director |
|
2019-05-08 |
4 |
S |
$257.88 |
$1,212,494 |
D/D |
(4,664) |
187,886 |
|
- |
|
Sutter Martin P |
Director |
|
2019-05-08 |
4 |
OE |
$7.67 |
$92,040 |
D/D |
12,000 |
192,550 |
|
- |
|
Trapp Todd A |
Vice President, CFO |
|
2019-04-09 |
4 |
D |
$282.95 |
$264,275 |
D/D |
(934) |
5,354 |
|
- |
|
Sutter Martin P |
Director |
|
2019-03-31 |
4 |
A |
$285.59 |
$16,850 |
D/D |
59 |
180,550 |
|
- |
|
Bolt William J |
SVP, QA and Regulatory Affairs |
|
2019-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
56 |
62,182 |
|
- |
|
Greenfield Andrew J |
VP Healthcare Solutions |
|
2019-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
25 |
44,003 |
|
- |
|
Minogue Michael R |
Chairman, President, CEO |
|
2019-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
51 |
376,201 |
|
- |
|
Sutter Martin P |
Director |
|
2019-02-15 |
4 |
S |
$360.23 |
$3,603,110 |
D/D |
(10,000) |
180,491 |
|
- |
|
Sutter Martin P |
Director |
|
2019-02-14 |
4 |
S |
$360.00 |
$1,800,000 |
D/D |
(5,000) |
190,491 |
|
- |
|
Sutter Martin P |
Director |
|
2019-02-13 |
4 |
S |
$360.00 |
$1,800,000 |
D/D |
(5,000) |
195,491 |
|
- |
|
Van Gorder Chris |
Director |
|
2019-02-08 |
4 |
D |
$341.61 |
$201,550 |
D/D |
(590) |
5,836 |
|
- |
|
Sutter Martin P |
Director |
|
2019-02-06 |
4 |
S |
$345.00 |
$2,091,670 |
D/D |
(5,985) |
200,491 |
|
- |
|
740 Records found
|
|
Page 11 of 30 |
|
|